Get the Stockscreener App
2.51
3.46%
-0.09
Orasure Technologies Inc stock is traded at $2.51, with a volume of 675.35K.
It is down -3.46% in the last 24 hours and down -20.57% over the past month.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
See More
Previous Close:
$2.60
Open:
$2.57
24h Volume:
675.35K
Relative Volume:
0.94
Market Cap:
$230.92M
Revenue:
$405.47M
Net Income/Loss:
$53.66M
P/E Ratio:
3.4861
EPS:
0.72
Net Cash Flow:
$131.28M
1W Performance:
-15.77%
1M Performance:
-20.57%
6M Performance:
-41.49%
1Y Performance:
-50.25%
1-Day Range:
$2.50
$2.61
1-Week Range:
$2.42
$2.945
52-Week Range:
$2.42
$5.55
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.51 | 230.92M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-23 | Resumed | Evercore ISI | In-line |
| Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-21-20 | Initiated | Evercore ISI | Outperform |
| Aug-10-20 | Initiated | Citigroup | Buy |
| Aug-10-20 | Initiated | JP Morgan | Neutral |
| Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-25-20 | Initiated | Lake Street | Buy |
| Apr-21-20 | Resumed | Stephens | Equal-Weight |
| Oct-23-18 | Resumed | Raymond James | Mkt Perform |
| Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
| Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-05-15 | Reiterated | Mizuho | Buy |
| May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-23-15 | Reiterated | Mizuho | Buy |
| Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
| Jun-11-14 | Reiterated | Mizuho | Buy |
| Dec-21-12 | Initiated | Mizuho | Buy |
| Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions - MSN
OraSure Executive Resigns, Effective June 30 - Investing.com
OraSure Technologies First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies Announces CPO Resignation - TipRanks
Orasure Technologies, Inc. Announces Resignation of Chief Product Officer Kathleen G. Weber Effective June 30, 2025 - marketscreener.com
Evercore ISI cuts OraSure stock price target to $3 from $4 - Investing.com Nigeria
Shareholders Will Probably Hold Off On Increasing OraSure Technologies, Inc.'s (NASDAQ:OSUR) CEO Compensation For The Time Being - simplywall.st
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
Earnings call transcript: OraSure’s Q1 2025 beats EPS forecast, stock stable - Investing.com
OraSure Technologies Reports Q1 2025 Financial Results - TipRanks
OraSure: Q1 Earnings Snapshot - The Washington Post
OraSure reports first quarter loss, but looks forward to emerging as 'stronger enterprise' - WFMZ.com
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
OraSure Technologies Reports Q1 2025 Revenue Decline - TipRanks
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OSUR Stock News - GuruFocus
OraSure (OSUR) Reports Q1 Revenue Slightly Above Expectations | OSUR Stock News - GuruFocus
OraSure Announces First Quarter 2025 Financial Results - The Manila Times
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies: Historically Cheap (NASDAQ:OSUR) - Seeking Alpha
Press Release Distribution & PR Platform - ACCESS Newswire
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th - The Manila Times
OraSure Technologies, Inc. Schedules Q1 2025 Earnings Conference Call for May 7, 2025 - Nasdaq
OraSure Q1 2025 Earnings Preview: Key Financial Metrics and Live Q&A Session Coming May 7 - Stock Titan
Your Guide to Rapid Testing for Syphilis, HIV & HCV - Labroots
OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference - marketscreener.com
GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains? - Nasdaq
Premier Biotech Increases Offerings and Global Distribution Network with Recent Acquisitions - The Joplin Globe
Drug Screening Market is Expected to Reach $19.5 billion | MarketsandMarkets™ - The Globe and Mail
OraSure Technologies (NASDAQ:OSUR shareholders incur further losses as stock declines 12% this week, taking five-year losses to 75% - Yahoo Finance
Insider Stock Buying Reaches US$761.0k On OraSure Technologies - simplywall.st
OraSure Technologies Elects Jack Kenny to the Board of Directors - marketscreener.com
OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025 - Insider Monkey
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
OraSure announces $40M stock buy back - Lehigh Valley Business
OraSure announces $40 million stock buyback plan By Investing.com - Investing.com Australia
OraSure announces $40 million stock repurchase program - WFMZ.com
OraSure Announces $40 Million Stock Repurchase Program - GlobeNewswire
OraSure announces $40 million stock buyback plan - Investing.com
OraSure Announces $40 Mln Stock Repurchase Program - Nasdaq
OraSure Technologies, Inc. announces an Equity Buyback for $40 million worth of its shares. - Marketscreener.com
OraSure Technologies' Board Approves Up to $40 Million Stock Buyback Plan -March 24, 2025 at 08:17 am EDT - Marketscreener.com
OraSure Technologies, Inc. Announces $40 Million Stock Repurchase Program - Nasdaq
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.40%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):